Article info
Correspondence response
Response to: ‘Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management’’ by Snarskaya and Vasileva
- Correspondence to Dr Marco Matucci-Cerinic, Department of Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze 50121, Italy; marco.matuccicerinic{at}unifi.it
Citation
Response to: ‘Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management’’ by Snarskaya and Vasileva
Publication history
- Received November 24, 2020
- Revised December 19, 2020
- Accepted December 21, 2020
- First published January 6, 2021.
Online issue publication
January 23, 2023
Article Versions
- Previous version (6 January 2021).
- Previous version (7 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage